Cargando…
Waldenström macroglobulinemia presenting as nephrotic syndrome: Renal heavy and light chain amyloidosis
Autores principales: | Kwakernaak, Arjan J., Bernelot Moens, Sophie J., Hilhorst, Marc L., Florquin, Sandrine, van de Donk, Niels W.C.J., Vos, Josephine M.I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175854/ https://www.ncbi.nlm.nih.gov/pubmed/35846067 http://dx.doi.org/10.1002/jha2.424 |
Ejemplares similares
-
Mast cell density and its clinical relevance in Waldenström's macroglobulinemia
por: Lemal, Richard, et al.
Publicado: (2022) -
Cutaneous amyloidosis as the first presentation of Waldenstrom macroglobulinemia
por: Rafiei, Rana, et al.
Publicado: (2020) -
A Focus on Waldenström Macroglobulinemia and AL Amyloidosis
por: Lu, Rebecca, et al.
Publicado: (2022) -
Light chain amyloidosis associated with Waldenström macroglobulinemia: treatment and survival outcomes
por: Gustine, Joshua N., et al.
Publicado: (2022) -
Concurrent Waldenstrom Macroglobulinemia and Mutant Transthyretin Cardiac Amyloidosis
por: Qian, Xiaoxiao, et al.
Publicado: (2022)